Stemtech (STEK) Current Deferred Revenue (2022 - 2025)

Stemtech has disclosed Current Deferred Revenue across 4 years of filings, most recently posting $171485.0 for Q4 2025.

• Current Deferred Revenue for Q4 2025 came in at $171485.0, up 11621.46% year-over-year; the trailing twelve-month figure through Dec 2025 was $171485.0 (up 11621.46% YoY), and the FY2025 annual result was $171485.0, up 11621.46% from the prior year.
• Current Deferred Revenue came in at $171485.0 for Q4 2025 at Stemtech, up from $88393.0 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $171485.0 in Q4 2025 to a low of $1463.0 in Q4 2024.
• The 4-year median for Current Deferred Revenue is $79149.5 (2023), against an average of $70696.2.
• Across the five-year window, Current Deferred Revenue sank 97.39% in 2024 and jumped 11621.46% in 2025, its largest moves.
• Stemtech's Current Deferred Revenue stood at $39170.0 in 2022, then surged by 43.07% to $56039.0 in 2023, then tumbled by 97.39% to $1463.0 in 2024, then surged by 11621.46% to $171485.0 in 2025.
• The last three Current Deferred Revenue figures came in at $171485.0 (Q4 2025), $88393.0 (Q3 2025), and $98249.0 (Q2 2025), per Business Quant data.